Furthermore, AM6545 (10 mg/kg/day), a peripheral CB1 antagonist, combined with angiotensin-converting enzyme (ACE) inhibitor, was shown to reverse albuminuria, nephrin loss, and to inhibit inflammation in rodent model of DN [232]. The gene discussed is CNR1; the disease is liver dysplastic nodule.